Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:ozonated autohemotherapy
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) In line with ethics, sign a written informed consent form; (2) Patients with positive detection of new coronavirus nucleic acid; (3) Chest CT confirmed pulmonary lesions; (4) Hospitalized patients with fever or respiratory symptoms; (5) Patients who did not participate in other clinical studies within three months.
Exclusion criteria
Exclusion criteria: (1) Hyperthyroidism; (2) Favism; (3) Pregnancy; (4) Abnormal coagulation, thrombocytopenia, active bleeding; (5) People with medical ozone allergy or hypersensitivity; (6) Severe anemia; (7) Hypocalcemia; (8) Unstable period of severe cardiovascular disease; (9) Uncontrolled diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Antifebrile time;Inflammatory absorption of chest CT;Intervals from positive to negative of Nucleic acid test;Time to Clinical recovery;Mortality rate;conversion rate of severe patients; | — |
Countries
China
Contacts
Public ContactChen Xiangdong
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed